Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04388605 · ClinicalTrials.gov registry record
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
A clinical trial of Pregnancy Related and Corona Virus Infection, sponsored by University of California, San Francisco.
- Active
- Registry status
- 7,965
- Enrollment target
- 1
- Study location
NCT04388605: Active study of Pregnancy Related and Corona Virus Infection, sponsored by University of California, San Francisco.
NCT04388605 is a study of Pregnancy Related and Corona Virus Infection that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 7,965 participants, above the 1,883-participant average among 99 other Pregnancy Related trials with a reported enrollment target (323% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04388605, a study of Pregnancy Related and Corona Virus Infection, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 7,965 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.
Primary Outcome
Determine the prevalence of SARS-CoV-2 infection throughout pregnancy in women whose pregnancy was documented at a SART member clinic in the United States between November 2019-December 2020. The investigators will use patient-reported information on infection symptoms as well as serological testing to capture both symptomatic and asymptomatic infections. Deliverable: By instituting the first prospectively tracked U.S.-based pregnancy cohort with precisely timed conception, the investigators wil
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,965 participants |
| Start Date | 2020-04-21 |
| Est. Completion | 2026-12 |
What the registry record for NCT04388605 still lists
NCT04388605 is an observational study that tracks outcomes without assigning an intervention. Its 7,965 participants enrollment target places it among the larger protocols in the corpus, above the 1,883-participant average among 99 other Pregnancy Related trials with a reported enrollment target (323% higher).
The record links to 4 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.
NCT04388605 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04388605 about?
NCT04388605 is a clinical study titled "Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic". Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.
What is the current status of trial NCT04388605?
This trial is currently active not recruiting. The enrollment target is 7,965 participants. The study started on 2020-04-21. Estimated completion is 2026-12.
What conditions does trial NCT04388605 study?
This clinical trial studies the following conditions: Pregnancy Related, Corona Virus Infection, COVID, Early Pregnancy.
Who is sponsoring clinical trial NCT04388605?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04388605 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04388605's enrollment target sits among peer trials
7,965 4th of 99 higher than 96 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI